Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Lawrence Solow
CJS
Lawrence Solow
CJS Securities
Wall Street Analyst
★★★★☆
#748
on 13Foresight · ranked by our own returns
57%
Success Rate
+18.8%
Average Return
8 of 14 calls profitable · +4.5% vs benchmark
📈 Across the calls we could measure, roughly 57% of Lawrence Solow's ratings turned a profit when each position was held for 1 year — averaging +18.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

3 Buy 0 Hold 0 Sell
Lawrence's Stock Coverage 13 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
BVS
Bioventus
 Mar 27, 2026 BUY Strong Buy
+41.0% avg upside
8 analysts
$14.00
60.70% Upside
 -3.4%
CODI
Compass Diversified Holdings
 Jan 27, 2026 BUY Strong Buy
+112.0% avg upside
13 analysts
$15.00
48.39% Upside
 +47.6%
ERII
Energy Recovery
 Sep 16, 2025 BUY Strong Buy
+60.2% avg upside
10 analysts
$19.00
101.74% Upside
 -43.4%
SXT
Sensient Technologies
 Jun 10, 2025 HOLD Buy
+4.9% avg upside
4 analysts
$95.00
16.20% Downside
 +26.2%
BTSG
BrightSpring Health Services, Inc.
 Dec 12, 2024 BUY Strong Buy
-16.3% avg upside
18 analysts
$27.00
59.18% Downside
 +103.7%
CDRE
Cadre Holdings
 Jun 10, 2024 BUY Strong Buy
+47.2% avg upside
8 analysts
$40.00
41.69% Upside
 +8.2%
STVN
Stevanato Group
 Sep 19, 2023 BUY Strong Buy
+53.7% avg upside
13 analysts
$36.00
105.18% Upside
 ·
USPH
US Physical Therapy
 Sep 19, 2023 BUY Strong Buy
+44.4% avg upside
12 analysts
 — -9.4%
RDNT
Radnet
 Mar 31, 2023 BUY Strong Buy
+49.3% avg upside
10 analysts
$30.00
44.21% Downside
 +94.4%
CLH
Clean Harbors
 Sep 21, 2021 BUY Strong Buy
-11.1% avg upside
23 analysts
$125.00
56.69% Downside
 +16.4%
HAE
Haemonetics
 May 14, 2021 BUY Buy
-9.2% avg upside
17 analysts
 — +0.4%
LNTH
Lantheus
 Oct 03, 2019 HOLD Strong Buy
-27.9% avg upside
20 analysts
$24.00
76.89% Downside
 -33.7%
ICUI
ICU Medical
 Sep 23, 2014 BUY Strong Buy
+14.9% avg upside
9 analysts
$80.00
42.91% Downside
 +83.5%
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Lawrence Solow — Frequently Asked Questions
How accurate are Lawrence Solow's stock ratings?
Based on the calls 13Foresight could measure, about 57% of Lawrence's ratings were profitable over a one-year hold, with an average return of +18.8% per rating, or +4.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Lawrence ranked on 13Foresight?
Lawrence Solow is currently ranked #748 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Lawrence cover?
Lawrence most recently has ratings on BVS, CODI, ERII, SXT, BTSG, CDRE, STVN, USPH, RDNT, CLH, HAE, LNTH and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.